Innovations in AI Risk-Based Monitoring in Clinical Research
Risk-based monitoring (RBM) is a useful tool in maximising the quality of clinical trials. Enhanced site communication, greater patient safety and lower costs are a few of the benefits of RBM. The innovations of AI in clinical research have application...
4 years agoInnovations in AI Risk-Based Monitoring in Clinical Research
Risk-based monitoring (RBM) is a useful tool in maximising the quality of clinical trials. Enhanced site communication, greater patient safety and lower costs are a few of the benefits of RBM. The innovations of AI in clinical research have application...
4 years ago
How Effective is the Automation and Validating of Human Dose Predictive Models?
Dose prediction is a critical part of drug discovery which determines the safety and efficacy of drugs within patients. Dose response predictions are made with preclinical models which quantify pharmacokinetic (PK) behaviour via a number of parameters. Despite the continuous...
4 years agoHow Effective is the Automation and Validating of Human Dose Predictive Models?
Dose prediction is a critical part of drug discovery which determines the safety and efficacy of drugs within patients. Dose response predictions are made with preclinical models which quantify pharmacokinetic (PK) behaviour via a number of parameters. Despite the continuous...
4 years ago
An Evaluation of -Omics Technology
Omics technologies have proven to be useful molecular tools across many therapeutic areas in facilitating qualitative and quantitative tissue analysis. Spatially Resolved Transcriptomics (SRT) is an example of -omics technology used in oncology to further investigate how the heterogeneity of...
4 years agoAn Evaluation of -Omics Technology
Omics technologies have proven to be useful molecular tools across many therapeutic areas in facilitating qualitative and quantitative tissue analysis. Spatially Resolved Transcriptomics (SRT) is an example of -omics technology used in oncology to further investigate how the heterogeneity of...
4 years ago
How Has COVID Affected Pharmaceutical Manufacturing?
In 2020 the COVID-19 pandemic threw the world into turmoil. The pharmaceutical industry needed to adapt rapidly to meet an increased demand, shifting clinical trials to virtual platforms and of course looking to accelerate COVID vaccine approval. It has become...
4 years agoHow Has COVID Affected Pharmaceutical Manufacturing?
In 2020 the COVID-19 pandemic threw the world into turmoil. The pharmaceutical industry needed to adapt rapidly to meet an increased demand, shifting clinical trials to virtual platforms and of course looking to accelerate COVID vaccine approval. It has become...
4 years ago
The Current Outlook for Investment in Oncology
Oncology alone accounts for one-third of the global clinical pipeline across all therapeutic areas. In 2024, the global oncology therapeutics sales are forecasted to hit $250 billion. As the world’s largest therapeutic area, it is a highly competitive market with...
4 years agoThe Current Outlook for Investment in Oncology
Oncology alone accounts for one-third of the global clinical pipeline across all therapeutic areas. In 2024, the global oncology therapeutics sales are forecasted to hit $250 billion. As the world’s largest therapeutic area, it is a highly competitive market with...
4 years ago
A Review of CGT: Viral and Non-Viral Approaches
Cell and gene therapies have remained at the forefront of biomedical research for the last decade. While the mechanisms of these therapies differ, both approaches have shown potential across a range of conditions to alleviate symptoms or potentially cure the...
4 years agoA Review of CGT: Viral and Non-Viral Approaches
Cell and gene therapies have remained at the forefront of biomedical research for the last decade. While the mechanisms of these therapies differ, both approaches have shown potential across a range of conditions to alleviate symptoms or potentially cure the...
4 years agoInterested?
Reserve your space
